tm logo

Monitor this mark

View On USPTO

XURIDEN
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 30 Jul 2021

Last Applicant/ Owned by

Wellstat Therapeutics Corporation

5 Fleet Place

London

EC4M7RD

Serial Number

85386985 filed on 02th Aug 2011

Registration Number

4822320 registered on 29th Sep 2015

in the Principal Register

Correspondent Address

Sherry L. Rollo

Sherry L. Rollo Hahn Loeser & Parks LLP

Suite 2700

Chicago, IL 60606

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XURIDEN

Pharmaceutical products and preparations for use in the field of neurodegenerative disease

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical products and preparations for use in the field of neurodegenerative disease

First Use Date in General

24th Jun 2015

First Use Date in Commerce

24th Jun 2015

Mark Details

Serial Number

No 85386985

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 219151.00030

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
06th Nov 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
18th Oct 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18th Oct 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
18th Oct 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
18th Oct 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
18th Oct 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18th Oct 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29th Sep 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12th Jul 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
30th Jul 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED